Republicans successfully stripped a proposed $35 per month cap on out-of-pocket spending on insulin for patients enrolled in private insurance from the tax and climate bill. The Senate parliamentarian had ruled that the provision, sponsored by Georgia Democratic Senator Raphael Warnock, is not primarily related to the federal budget. That gave the GOP a chance to raise a procedural objection. Waiving the rules required 60 votes to succeed. Seven Republicans sided with Democrats to keep the… Source link
Read More »Walmart launches private label insulin brand at steep discounts for diabetes patients
Walmart (WMT) is launching the first-ever and only private brand analog insulin, offering a steep discount on the prescription used to control high blood sugar in millions of diabetes patients. The new brand, ReliOn NovoLog, includes analog insulin vials retailing for $72.88 and a FlexPen selling for $85.88, translating to savings of 58% and 75%, respectively, on the current cash price of branded insulin products when not using insurance. According to Walmart, that works out to be savings of… Source link
Read More »